ReviewFrontiers in pharmacology2019

Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate.

Abdelrahman Ibrahim Abushouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.